A detailed history of Perkins Capital Management Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Perkins Capital Management Inc holds 180,800 shares of NEO stock, worth $2.98 Million. This represents 2.62% of its overall portfolio holdings.

Number of Shares
180,800
Previous 187,300 3.47%
Holding current value
$2.98 Million
Previous $2.6 Million 2.66%
% of portfolio
2.62%
Previous 2.56%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$13.4 - $17.73 $87,100 - $115,245
-6,500 Reduced 3.47%
180,800 $2.67 Million
Q2 2024

Aug 09, 2024

SELL
$13.01 - $15.77 $76,759 - $93,043
-5,900 Reduced 3.05%
187,300 $2.6 Million
Q4 2023

Jan 22, 2024

SELL
$11.67 - $20.73 $8,752 - $15,547
-750 Reduced 0.39%
193,200 $3.13 Million
Q3 2023

Nov 02, 2023

SELL
$12.15 - $17.85 $30,982 - $45,517
-2,550 Reduced 1.3%
193,950 $2.39 Million
Q2 2023

Jul 21, 2023

SELL
$14.1 - $19.83 $7,050 - $9,915
-500 Reduced 0.25%
196,500 $3.16 Million
Q1 2023

May 09, 2023

SELL
$9.09 - $19.45 $6,363 - $13,615
-700 Reduced 0.35%
197,000 $3.43 Million
Q4 2022

Jan 26, 2023

BUY
$6.45 - $12.07 $13,867 - $25,950
2,150 Added 1.1%
197,700 $1.83 Million
Q3 2022

Oct 24, 2022

SELL
$7.86 - $12.91 $55,020 - $90,370
-7,000 Reduced 3.46%
195,550 $1.68 Million
Q2 2022

Jul 29, 2022

BUY
$7.06 - $13.97 $353,000 - $698,500
50,000 Added 32.78%
202,550 $1.65 Million
Q1 2022

Apr 20, 2022

SELL
$12.15 - $35.28 $36,450 - $105,840
-3,000 Reduced 1.93%
152,550 $1.85 Million
Q4 2021

Feb 10, 2022

SELL
$30.49 - $48.49 $67,078 - $106,678
-2,200 Reduced 1.39%
155,550 $5.31 Million
Q3 2021

Oct 25, 2021

SELL
$41.66 - $52.52 $22,912 - $28,886
-550 Reduced 0.35%
157,750 $7.61 Million
Q2 2021

Jul 28, 2021

SELL
$36.62 - $51.69 $91,550 - $129,225
-2,500 Reduced 1.55%
158,300 $7.15 Million
Q1 2021

Apr 28, 2021

SELL
$41.56 - $59.88 $849,902 - $1.22 Million
-20,450 Reduced 11.28%
160,800 $7.76 Million
Q4 2020

Feb 09, 2021

SELL
$36.08 - $56.47 $659,362 - $1.03 Million
-18,275 Reduced 9.16%
181,250 $9.76 Million
Q3 2020

Oct 28, 2020

SELL
$33.26 - $40.48 $1.17 Million - $1.43 Million
-35,325 Reduced 15.04%
199,525 $7.36 Million
Q1 2020

Apr 29, 2020

SELL
$20.5 - $34.53 $361,825 - $609,454
-17,650 Reduced 6.99%
234,850 $6.48 Million
Q4 2019

Feb 03, 2020

SELL
$18.96 - $29.84 $185,808 - $292,432
-9,800 Reduced 3.74%
252,500 $7.39 Million
Q3 2019

Oct 23, 2019

SELL
$19.12 - $26.24 $332,688 - $456,576
-17,400 Reduced 6.22%
262,300 $5.02 Million
Q2 2019

Aug 09, 2019

BUY
$19.57 - $24.1 $294,528 - $362,705
15,050 Added 5.69%
279,700 $6.14 Million
Q1 2019

Apr 22, 2019

SELL
$12.14 - $20.46 $204,559 - $344,751
-16,850 Reduced 5.99%
264,650 $5.42 Million
Q4 2018

Feb 11, 2019

SELL
$11.24 - $18.5 $26,976 - $44,400
-2,400 Reduced 0.85%
281,500 $3.55 Million
Q3 2018

Oct 22, 2018

SELL
$12.5 - $15.38 $73,750 - $90,742
-5,900 Reduced 2.04%
283,900 $4.36 Million
Q2 2018

Aug 02, 2018

SELL
$7.99 - $14.05 $24,369 - $42,852
-3,050 Reduced 1.04%
289,800 $3.8 Million
Q1 2018

Apr 23, 2018

SELL
$7.23 - $8.76 $36,150 - $43,800
-5,000 Reduced 1.68%
292,850 $2.39 Million
Q4 2017

Jan 26, 2018

SELL
$8.02 - $11.18 $83,809 - $116,831
-10,450 Reduced 3.39%
297,850 $2.64 Million
Q3 2017

Oct 31, 2017

BUY
$9.11 - $11.26 $2.81 Million - $3.47 Million
308,300
308,300 $3.43 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.07B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.